Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study

The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review

(2018) Saber Yezli   Travel Medicine and Infectious Disease

Vaccines for the elderly: current use and future challenges

(2018) Birgit Weinberger   Immunity & Ageing

Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine

(2017) Amanda C. Cohn et al.   PEDIATRICS

Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth

(2017) Meredith G Warshaw et al.   Journal of the Pediatric Infectious Diseases Society

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

(2016) Ray Borrow et al.   Expert Review of Vaccines

Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine

(2016) Corwin A. Robertson et al.   VACCINE

Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants

(2016) Roger Baxter et al.   Human Vaccines & Immunotherapeutics

Safety and Immunogenicity of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants and Toddlers

(2012) L. Miriam Pina et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis

(2009) David S. Stephens   VACCINE